Latest News and Press Releases
Want to stay updated on the latest news?
-
Capital Structure Simplification, AI Product Strategy, and Path to Sustainable Growth in Focus SOMERSET, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or...
-
Tustin, CA, May 11, 2026 (GLOBE NEWSWIRE) -- CalEthos, Inc. (OTCQB:GEDC), and its subsidiary TerraVolt Infrastructure, Inc. (“TerraVolt” or, collectively with CalEthos, Inc., the “Company”), today...
-
Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Business Jet Market Report by Type, Business Model, System Analysis, Countries and Company Analysis 2026-2034" report has been added to ...
-
RA'ANANA, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies," or the "Company"), today issued a letter to its...
-
Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027Recently resumed patient screening in MAGNITUDE...
-
ROE triples its manufacturing capacity for high-precision, multi-material monolithic dentures, capitalizing on early success with the NextDent® 300 jetted-denture solution to meet accelerating U.S....
-
Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issuesResults allow for...
-
Recent Facility Upgrades Expand Company’s Leadership Position with World’s Largest EU-GMP Certified Cannabis Facility; International Export Sales Grew 171% as Demand Continues to IncreaseConsolidated...
-
VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) -- Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF, FSE: 9I3) (“Coppernico” or the “Company”) is pleased to provide an exploration update...
-
Elraglusib oral tablet formulation to drive next-phase clinical development and broader clinical useFDA cleared IND for Phase 1/2 study of oral elraglusib in advanced cancer patients, with focus on...